Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection.
Bichoupan K, Tandon N, Martel-Laferriere V, Patel NM, Sachs D, Ng M, Schonfeld EA, Pappas A, Crismale J, Stivala A, Khaitova V, Gardenier D, Linderman M, Olson W, Perumalswami PV, Schiano TD, Odin JA, Liu LU, Dieterich DT, Branch AD.
Bichoupan K, et al. Among authors: crismale j.
World J Hepatol. 2017 Apr 18;9(11):551-561. doi: 10.4254/wjh.v9.i11.551.
World J Hepatol. 2017.
PMID: 28469811
Free PMC article.